Absence of Integrase Inhibitor-Associated Resistance Among Antiretroviral Therapy-Naïve HIV-1-Infected Adults in Guangdong Province, China, in 2018.

Yun LanLinghua LiWeilie ChenXizi DengJunbin LiQinghong FanXiaoli CaiWeiping CaiFengyu Hu

Published in: Infection and drug resistance (2020)

The overall prevalence of INSTI mutations remains low. Drug resistance mutation testing for the detection of INSTI drug resistance mutations in HIV treatment-naïve patients should be considered due to the circulation of polymorphisms contributing to INSTI resistance and the expected increasing use of this class of drugs.

Keyphrases

antiretroviral therapy
hiv infected
human immunodeficiency virus
hiv positive
hiv aids
hiv infected patients
end stage renal disease
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
risk factors
south africa
quantum dots
replacement therapy